Friday | 5 December, 2008
Stories about: Ambri
- +
Ambri boss adds perspective to US partner's decision 06/02/2006 14:28:10
Sydney biosensor specialist Ambri (ASX:ABI) appeared to hit a setback last week, when the company announced that its US partner would no longer work to develop Ambri's ion-channel switch (ICS). - +
Ambri tech development dropped by US partner 02/02/2006 14:25:47
Biosensor Enterprises (BEL) will no longer work to develop Sydney-based Ambri's (ASX:ABI) ion-channel switch (ICS), and will instead focus on out-licensing the technology. - +
Ambri on the hunt for M&A targets 30/11/2005 13:50:10
Sydney-based Ambri (ASX:ABI) is looking to merge with another medical diagnostics company with products that are closer to market. - +
Ambri revenue, loss down 25/08/2005 13:54:21
Ambri (ASX:ABI) saw a decrease in its revenue for the 2004-05 financial year of 27 per cent to $1 million (from $1.4 million in the previous year) but the company's loss was also down 22 per cent to $9 million. - +
Transforming technology 22/06/2005 08:51:08
The nanotech sector in Australia is growing with potential. - +
We're open for business: CSIRO exec 06/06/2005 08:59:14
The new executive director of CSIRO's business development team, Nigel Poole, is on the campaign trail, seeking to convince the business world that the organisation is open for business. - +
Aust biotech posts three-year performance low: PwC 31/05/2005 12:17:24
A new report on ASX-listed life sciences companies by PricewaterhouseCoopers shows that the sector has posted its worst quarterly performance in three years. - +
Ambri back to the drawing board 24/05/2005 14:45:49
Medical diagnostics company Ambri (ASX:ABI) is busy back at the drawing board developing a new chip biosensor after suspending the development of its SensiDX project. - +
Ambri reveals plans to slash workforce 24/02/2005 14:48:34
Medical diagnostics company Ambri (ASX:ABI) has announced plans to halve its workforce and is on the hunt for new medical diagnostic products to shore up its product pipeline after the suspension last year of its SensiDX project. - +
In brief: Ambri; QIC; Solbec; IDT 13/12/2004 14:44:37
Sydney-based biosensor developer Ambri (ASX:ABI) has made chief financial officer Jeff Carter redundant, citing a drive to redirect resources towards its biosensor platform. Ambri's current financial controller, Phillip Camilleri, will assume the role of company secretary, and take over responsibility of all financial matters. - +
New head named for QBF 02/12/2004 15:30:02
Neill Colledge, the senior portfolio manager and head of research for domestic equities at Queensland Investment Corporation (QIC), has replaced Kathryn Radford as CEO of the AUD$100 million Queensland BioCapital Funds (QBF).
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
IDC Says Asia/Pacific Excluding Japan IT Market Will Remain The Bright Spot... 2008-12-04 15:04:00+11
AOC Launches 18.5” Widescreen Green 16:9 LCD Monitor in Australia and New Zealand 2008-12-03 15:30:00+11
“Just Graphics” isn’t enough any more 2008-11-28 15:02:00+11
Capture and Digitize Your Treasure Moments ~ Compro VideoMate C200 USB A/V Capture Stick 2008-11-26 12:37:00+11
AOC's Widescreen 22" LCD Monitor with All-Aluminum Chassis: Zifas 2218Ph - Flexible flair for discerning users 2008-11-24 13:30:00+11
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector.
